Changes in insulin binding during hemodialysis in uremic patients.
To investigate factors responsible for altered insulin sensitivity in uremia, we studied 125I-insulin binding to erythrocytes in 20 uremic patients before and after dialysis. In uremic patients, predialysis binding was 50% lower in comparison with healthy controls (4.35 +/- 1.79 vs. 9.37 +/- 1.30%; p less than 0.01). Five-hour dialysis treatment resulted in a rapid increase in binding (on average to 55%; p less than 0.01). During the course of dialysis, binding to erythrocytes from 2 selected patients steadily increased in a time-dependent manner (on average 24%/h). The dialysis-induced increase in binding did not correlate with the changes in plasma insulin levels, but depended on the efficiency of dialysis as assessed by a relative decrease in plasma urea and creatinine. After an intravenous glucose load, the insulin-to-glucose ratio decreased in parallel with the increase in binding after dialysis. The results indicate that uremic plasma contains dialyzable substances which reversibly inhibit insulin binding, leading to altered insulin sensitivity.
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D003404:Creatinine / Q000097:blood; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood*; D007457:Iodine Radioisotopes; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D011972:Receptor, Insulin / Q000378:metabolism; D006435:Renal Dialysis; D014508:Urea / Q000097:blood; D014511:Uremia / Q000097:blood / Q000628:therapy*; D014527:Uric Acid / Q000097:blood
D001786:Blood Glucose; D007328:Insulin; D007457:Iodine Radioisotopes; D014527:Uric Acid; D014508:Urea; D003404:Creatinine; D011972:Receptor, Insulin